Top Story

Oral DAAs effective for HIV/HCV patients

May 5, 2015

New all-oral, direct-acting antiviral agents were well tolerated and showed encouraging signs of virological efficacy in a study of cirrhotic patients coinfected with HIV and hepatitis C virus, according to research presented at the 2015 International Liver Congress.

“Cirrhotic HIV-HCV coinfected patients have long been considered as difficult-to-treat patients with a high mortality rate,” Philippe Sogni, MD, of the Université Paris Descartes, and colleagues wrote. “Real-life efficacy and tolerance data with sofosbuvir-based combinations in cirrhotic HIV-coninfected patients are scarce and urgently needed.”

Indiana HIV prevention efforts expand to travelers, truck drivers

May 4, 2015
You Are Not Alone, the Indiana State Department of Health’s HIV public awareness campaign, has been expanded to include messages aimed at reaching travelers and…
Meeting News Coverage

2014 enterovirus D68 outbreak prevalent in children with asthma

May 4, 2015
Enterovirus D68 was associated with rampant, severe respiratory illness in children, particularly those with asthma, according to a study presented at the CDC’s…
Thomas A. Gustafson, PhD Health Care Legislative and Regulatory Update

Are you in an Alternative Payment Model? Why it matters

May 4, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
Jason Newland In the Journals

Despite limitations, Twitter benefits infectious disease specialists

May 4, 2015
Infectious disease specialists should familiarize themselves with Twitter so that they may educate fellow users and disseminate breaking news within the field…
More News Headlines »
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »